Profile
Theo Proukou is currently the Chief HR Officer & Executive Partner at Flagship Pioneering.
Prior to this, he held various HR leadership roles at Novartis Vaccines & Diagnostics, Vertex Pharmaceuticals, TripAdvisor, and Rubius Therapeutics.
He received his undergraduate and graduate degrees from St. Bonaventure University and an MBA.
Former positions of Theo Proukou
| Companies | Position | End |
|---|---|---|
| RUBIUS THERAPEUTICS | Human Resources Officer | 2022-03-31 |
| TRIPADVISOR, INC. | Corporate Officer/Principal | 2019-01-31 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 2016-03-31 |
Novartis Vaccines & Diagnostics, Inc.
 Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 2014-02-01 |
Training of Theo Proukou
| St. Bonaventure University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| TRIPADVISOR, INC. | Consumer Services |
| Private companies | 2 |
|---|---|
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Health Technology |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
- Stock Market
- Insiders
- Theo Proukou
